Nakajo M, Jinnouchi S, Noguchi M, Uozumi K, Tanabe H, Tateno R, Nakajo M. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease. Clin Nucl Med. 2007 Apr;32(4):282-5. doi: 10.1097/01.rlu.0000257295.12017.ab.
Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
Nanni C, Romagnoli R, Rambaldi I, Caroli P, Matteucci F, Ambrosini V, Re G, Fanti S. FDG PET/CT in autoimmune pancreatitis. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1264-5. doi: 10.1007/s00259-014-2699-5.
Santhosh S, Bhattacharya A, Harisankar CN, Kochhar R, Mittal BR. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations. Clin Nucl Med. 2013 Nov;38(11):e423-5. doi: 10.1097/RLU.0b013e31827086b5.
Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
Dong A, Cui Y, Gao L, Wang Y, Zuo C, Yang J. Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdom Imaging. 2014 Feb;39(1):175-86. doi: 10.1007/s00261-013-0041-5.
Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D., von Schulthess, G. K., & Goerres, G. W. (2004). Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?. Radiology, 232(3), 823–829. https://doi.org/10.1148/radiol.2323030985
Sireesha P, Nithya V, Surya G, Hemalatha DS, Kalawat T, Kumar VS, Priya RR. A Rare Finding of Pancreatic Involvement in a Case of Burkitt's Lymphoma. Indian J Nucl Med. 2023 Jan-Mar;38(1):59-62. doi: 10.4103/ijnm.ijnm_108_22.
Arslan E, Aksoy T, Alçın G, Ermantaş N, Özlük Y, Yeğen G, Çermik TF. Diffuse Large B-Cell Non-Hodgkin Lymphoma Involving Multiple Different Organs in a Young Adult with 18F-FDG PET/CT. Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):72-74. doi: 10.4274/mirt.galenos.2021.28190.
Farahmandfar F, Shakeri S, Moradian S, Shahlaei S, Sadeghi R. Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT. Nucl Med Rev Cent East Eur. 2020;23(2):108-109. doi: 10.5603/NMR.2020.0021.
Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
This is the report of three cases with diagnosis of Lymphoma who has pancreatic involvement as well as disseminated disease presentation as demonstrated by F-18 FDG PET/CT.
Nakajo M, Jinnouchi S, Noguchi M, Uozumi K, Tanabe H, Tateno R, Nakajo M. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease. Clin Nucl Med. 2007 Apr;32(4):282-5. doi: 10.1097/01.rlu.0000257295.12017.ab.
Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
Nanni C, Romagnoli R, Rambaldi I, Caroli P, Matteucci F, Ambrosini V, Re G, Fanti S. FDG PET/CT in autoimmune pancreatitis. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1264-5. doi: 10.1007/s00259-014-2699-5.
Santhosh S, Bhattacharya A, Harisankar CN, Kochhar R, Mittal BR. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations. Clin Nucl Med. 2013 Nov;38(11):e423-5. doi: 10.1097/RLU.0b013e31827086b5.
Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
Dong A, Cui Y, Gao L, Wang Y, Zuo C, Yang J. Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdom Imaging. 2014 Feb;39(1):175-86. doi: 10.1007/s00261-013-0041-5.
Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D., von Schulthess, G. K., & Goerres, G. W. (2004). Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?. Radiology, 232(3), 823–829. https://doi.org/10.1148/radiol.2323030985
Sireesha P, Nithya V, Surya G, Hemalatha DS, Kalawat T, Kumar VS, Priya RR. A Rare Finding of Pancreatic Involvement in a Case of Burkitt's Lymphoma. Indian J Nucl Med. 2023 Jan-Mar;38(1):59-62. doi: 10.4103/ijnm.ijnm_108_22.
Arslan E, Aksoy T, Alçın G, Ermantaş N, Özlük Y, Yeğen G, Çermik TF. Diffuse Large B-Cell Non-Hodgkin Lymphoma Involving Multiple Different Organs in a Young Adult with 18F-FDG PET/CT. Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):72-74. doi: 10.4274/mirt.galenos.2021.28190.
Farahmandfar F, Shakeri S, Moradian S, Shahlaei S, Sadeghi R. Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT. Nucl Med Rev Cent East Eur. 2020;23(2):108-109. doi: 10.5603/NMR.2020.0021.
There are 11 citations in total.
Details
Primary Language
English
Subjects
Gastroenterology and Hepatology, Nuclear Medicine, Haematological Tumours, Oncology and Carcinogenesis (Other)
Koç, Z. P., Özcan, P. P., & Yaraş, S. (2024). Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging, 4(1), 7-10.
AMA
Koç ZP, Özcan PP, Yaraş S. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. May 2024;4(1):7-10.
Chicago
Koç, Zehra Pınar, Pınar Pelin Özcan, and Serkan Yaraş. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging 4, no. 1 (May 2024): 7-10.
EndNote
Koç ZP, Özcan PP, Yaraş S (May 1, 2024) Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging 4 1 7–10.
IEEE
Z. P. Koç, P. P. Özcan, and S. Yaraş, “Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”, Molecular Oncologic Imaging, vol. 4, no. 1, pp. 7–10, 2024.
ISNAD
Koç, Zehra Pınar et al. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging 4/1 (May 2024), 7-10.
JAMA
Koç ZP, Özcan PP, Yaraş S. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2024;4:7–10.
MLA
Koç, Zehra Pınar et al. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging, vol. 4, no. 1, 2024, pp. 7-10.
Vancouver
Koç ZP, Özcan PP, Yaraş S. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2024;4(1):7-10.